Cargando…
Microbes, Histology, Blood Analysis, Enterotoxins, and Cytokines: Findings From the ASERF Systemic Symptoms in Women–Biospecimen Analysis Study: Part 3
BACKGROUND: There has been an increasing need to acquire rigorous scientific data to answer the concerns of physicians, patients, and the FDA regarding the self-reported illness identified as breast implant illness (BII). There are no diagnostic tests or specific laboratory values to explain the rep...
Autores principales: | McGuire, Patricia, Glicksman, Caroline, Wixtrom, Roger, Sung, C James, Hamilton, Robert, Lawrence, Marisa, Haws, Melinda, Ferenz, Sarah, Kadin, Marshall |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896138/ https://www.ncbi.nlm.nih.gov/pubmed/35980942 http://dx.doi.org/10.1093/asj/sjac225 |
Ejemplares similares
-
Impact of Capsulectomy Type on Post-Explantation Systemic Symptom Improvement: Findings From the ASERF Systemic Symptoms in Women-Biospecimen Analysis Study: Part 1
por: Glicksman, Caroline, et al.
Publicado: (2021) -
Longevity of Post-Explantation Systemic Symptom Improvement and Potential Etiologies: Findings From the ASERF Systemic Symptoms in Women–Biospecimen Analysis Study: Part 4
por: Glicksman, Caroline, et al.
Publicado: (2023) -
Heavy Metals in Breast Implant Capsules and Breast Tissue: Findings from the Systemic Symptoms in Women–Biospecimen Analysis Study: Part 2
por: Wixtrom, Roger, et al.
Publicado: (2022) -
Management of Asymptomatic Patients With Textured Surface Breast Implants
por: McGuire, Patricia A, et al.
Publicado: (2019) -
Report on Mortality from Gluteal Fat Grafting: Recommendations from the ASERF Task Force
por: Mofid, M Mark, et al.
Publicado: (2017)